COLUMBUS trial – 7 years data – Optimizing treatment outcomes for patients with BRAF mutant melanoma

Under detta möte diskuterade experter det senaste inom behandlingen av BRAF-mutant melanom.

Professor Reinhard Dummer is Professor of the University of Zürich and Vice-Chairman of the Department of Dermatology in the University Hospital of Zürich, Switzerland and is a key thought leader in worldwide cutaneous oncology. Currently he is heading of the Skin Cancer Unit and the Clinical Trial Unit of the Department of Dermatology.Professor Dummer began his medical education in haematology and oncology before successfully completing his dermatology residency in Würzburg, Germany, and Zürich in 1992.

He is Board Certified in allergology, clinical immunology, dermatology and dermatopathology.

Professor Dummer’s principal research interests are molecular biology, immunology and immunotherapy of cutaneous malignancies, including cutaneous lymphomas and melanomas. He has published approximately 1000 papers with a cumulative impact factor of more than 7199.039. He was past-president of the Melanoma Project Group of the Swiss Institute for Applied Cancer Research, 1999-2016. He is a member of the German National Academy of Sciences (Leopoldina) and is a past board member of the Society for Melanoma Research and past President of the International Society for Cutaneous Lymphomas.

He is a founding and board member of the European Association of Dermato-Oncology (EADO), ESMO, EATI, URPP and past President of the European Society for Dermatological Research (ESDR).

Professor Dummer has been a member of the ESMO Open Editorial Board since 2016, and of the Cancer Research ESMO Faculty Group.

Oslo

Helsingfors